People

Ali Tafreshi

Ali Tafreshi is Chief Technology Advisor at Amydis. His experience spans glaucoma, neuro-ophthalmology, retinal conditions and clinical trials, including research at the Hamilton Glaucoma Research Center and product management and clinical affairs at Heidelberg Engineering. Topcon Healthcare CEO, explicitly retained in the October 6, 2026 Oku launch announcement. Also CEO of the separately launched Oku Digital Health and global EyeCare chief strategy officer at parent Topcon Corporation. His former combined CEO/president title was superseded when Lance Patton became president in April 2026.

Roles

Amydis

Chief Technology Advisor

Current
Senseye, Inc. (Mental Health)

Board Director (reported October 2025)

Current
Topcon Healthcare Inc

Chief Executive Officer

Current